What is Alivus Life Sciences Price-to-Operating-Cash-Flow?
As of today (2025-05-22), Alivus Life Sciences's share price is ₹1103.60.
Alivus Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00. Hence, Alivus Life Sciences's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Alivus Life Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:
NSE:ALIVUS'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 34.61
Current: 34.61
During the past 7 years, Alivus Life Sciences's highest Price-to-Operating-Cash-Flow Ratio was 34.61. The lowest was 0.00. And the median was 0.00.
Alivus Life Sciences's Cash Flow from Operations per share for the
three
months ended in Mar. 2025 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Alivus Life Sciences was -5.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -14.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.80% per year.
During the past 7 years, Alivus Life Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 291.90% per year. The lowest was -14.40% per year. And the median was 9.15% per year.
Alivus Life Sciences Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Alivus Life Sciences's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alivus Life Sciences Price-to-Operating-Cash-Flow Chart
|
Alivus Life Sciences Annual Data
|
|
Trend |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
9.03 |
15.68 |
23.00 |
33.88 |
|
Alivus Life Sciences Quarterly Data
|
|
Mar20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
23.00 |
- |
- |
- |
33.88 |
Competitive Comparison of Alivus Life Sciences's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alivus Life Sciences's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Alivus Life Sciences's Price-to-Operating-Cash-Flow falls into.
Alivus Life Sciences Price-to-Operating-Cash-Flow Calculation
Alivus Life Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 1103.60 | / | 0 |
| = | |
Alivus Life Sciences's Share Price of today is ₹1103.60.
Alivus Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Alivus Life Sciences Business Description
Traded in Other Exchanges
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.
Alivus Life Sciences Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:ALIVUS has been successfully added to your